230 related articles for article (PubMed ID: 21206140)
21. Multiallergen immunotherapy for allergic rhinitis and asthma.
Nelson HS
J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
Chelladurai Y; Suarez-Cuervo C; Erekosima N; Kim JM; Ramanathan M; Segal JB; Lin SY
J Allergy Clin Immunol Pract; 2013; 1(4):361-9. PubMed ID: 24565541
[TBL] [Abstract][Full Text] [Related]
23. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review.
Kim JM; Lin SY; Suarez-Cuervo C; Chelladurai Y; Ramanathan M; Segal JB; Erekosima N
Pediatrics; 2013 Jun; 131(6):1155-67. PubMed ID: 23650298
[TBL] [Abstract][Full Text] [Related]
24. Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective?
Nelson HS
J Allergy Clin Immunol Pract; 2014; 2(2):144-9; quiz 150-1. PubMed ID: 24607040
[TBL] [Abstract][Full Text] [Related]
25. Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison.
Dretzke J; Meadows A; Novielli N; Huissoon A; Fry-Smith A; Meads C
J Allergy Clin Immunol; 2013 May; 131(5):1361-6. PubMed ID: 23557834
[TBL] [Abstract][Full Text] [Related]
26. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study.
Khinchi MS; Poulsen LK; Carat F; André C; Hansen AB; Malling HJ
Allergy; 2004 Jan; 59(1):45-53. PubMed ID: 14674933
[TBL] [Abstract][Full Text] [Related]
27. Sublingual immunotherapy.
Lin SY; Leatherman B
Otolaryngol Clin North Am; 2011 Jun; 44(3):753-64, x-xi. PubMed ID: 21621059
[TBL] [Abstract][Full Text] [Related]
28. A pilot study of feasibility of ultra-rush (20-25 minutes) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and/or asthma.
Rossi RE; Monasterolo G
Int J Immunopathol Pharmacol; 2005; 18(2):277-85. PubMed ID: 15888250
[TBL] [Abstract][Full Text] [Related]
29. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy.
Cochard MM; Eigenmann PA
J Allergy Clin Immunol; 2009 Aug; 124(2):378-9. PubMed ID: 19541352
[No Abstract] [Full Text] [Related]
30. Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trials.
Calderon MA; Eichel A; Makatsori M; Pfaar O
Curr Opin Allergy Clin Immunol; 2012 Jun; 12(3):249-56. PubMed ID: 22499145
[TBL] [Abstract][Full Text] [Related]
31. Clinical data and inflammation parameters in patients with cypress allergy treated with sublingual swallow therapy and subcutaneous immunotherapy.
Ventura MT; Carretta A; Tummolo RA; Buquicchio R; Arsieni A; Murgia N
Int J Immunopathol Pharmacol; 2009; 22(2):403-13. PubMed ID: 19505393
[TBL] [Abstract][Full Text] [Related]
32. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual.
Cox L; Wallace D
Immunol Allergy Clin North Am; 2011 Aug; 31(3):561-99. PubMed ID: 21737043
[TBL] [Abstract][Full Text] [Related]
33. Allergic rhinitis. Outcomes of immunotherapy on symptom control.
Cook PR
Otolaryngol Clin North Am; 1998 Feb; 31(1):129-40. PubMed ID: 9530682
[TBL] [Abstract][Full Text] [Related]
34. Meta-analyses of specific immunotherapy trials.
Calderon MA
Drugs Today (Barc); 2008 Dec; 44 Suppl B():31-4. PubMed ID: 19221615
[No Abstract] [Full Text] [Related]
35. [Sublingual immunotherapy (SLIT) in the allergologist's practice].
Mösges R; Köberlein J; Keppler J
MMW Fortschr Med; 2008 Jun; 150 Suppl 2():79-84. PubMed ID: 18712127
[No Abstract] [Full Text] [Related]
36. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile.
Calderón MA; Simons FE; Malling HJ; Lockey RF; Moingeon P; Demoly P
Allergy; 2012 Mar; 67(3):302-11. PubMed ID: 22150126
[TBL] [Abstract][Full Text] [Related]
37. Comparing the compliance to a short schedule of subcutaneous immunotherapy and to sublingual immunotherapy during three years of treatment.
Manzotti G; Riario-Sforza GG; Dimatteo M; Scolari C; Makri E; Incorvaia C
Eur Ann Allergy Clin Immunol; 2016 Nov; 48(6):224-227. PubMed ID: 27852426
[TBL] [Abstract][Full Text] [Related]
38. [Allergen specific immunotherapy: new approaches].
Tay F; Kündig TM; Senti G
Praxis (Bern 1994); 2010 Oct; 99(21):1279-84. PubMed ID: 20960398
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in specific immunotherapy for allergic rhinitis.
Bousquet J; Hejjaoui A; Michel FB
Clin Exp Allergy; 1991 Jan; 21 Suppl 1():259-61. PubMed ID: 2032157
[No Abstract] [Full Text] [Related]
40. The Relationship of Pollen Dispersal with Allergy Symptoms and Immunotherapy: Allergen Immunotherapy Improves Symptoms in the Late Period of Japanese Cedar Pollen Dispersal.
Sakurai T; Yonekura S; Iinuma T; Sakurai D; Morimoto Y; Kaneko S; Okamoto Y
Int Arch Allergy Immunol; 2018; 177(3):245-254. PubMed ID: 30021201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
